Navigation Links
Charleston Laboratories, Inc. Begins Enrollment for CL-108 Phase 3 Clinical Trial
Date:1/28/2013

CHARLESTON, S.C., Jan. 28, 2013 /PRNewswire/ -- Charleston Laboratories, Inc, an emerging specialty pharmaceutical company focused on the research and development of novel pain products that prevent or significantly reduce nausea and vomiting related to opioid analgesics and other pain associated disease states, announced today that patient enrollment has begun for the company's pivotal Phase 3 clinical trial for its first product, CL-108, for the treatment of moderate to severe pain.

"The initiation of this study marks the culmination of work by many people," said Dr. Bernard P. Schachtel , Chief Scientific Officer of Charleston.  "In addition to input by our scientific, clinical and regulatory advisors, the investigators at the research centers where this study is being conducted also contributed to the protocol."  Dr. Schachtel noted in particular the advice of Dr. Elliot V. Hersh , Professor of Oral & Maxillofacial Surgery and Pharmacology at the University of Pennsylvania, where Dr. Hersh is Principal Investigator for the trial.  "As exemplified by the enthusiasm and dedication of the many doctors, nurses, study coordinators, and other researchers at our recent Investigators Meeting," Dr. Schachtel continued, "this study offers the rare and exciting opportunity to research a truly novel indication, the treatment of both moderate to severe pain and the nausea and vomiting commonly associated with its treatment."  

"This day represents a major milestone for Charleston in our quest to develop differentiated and innovative pain products," said Paul Bosse , President and Chief Executive Officer of Charleston.  "I am proud of the Charleston team, specifically the critical roles they played in drug manufacturing, regulatory affairs and project ma
'/>"/>

SOURCE Charleston Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
2. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
3. IncellDx, Inc. Announces an Agreement with BioReference Laboratories, Inc. to Conduct a 10,000 Sample Study Using a Slideless Pap Smear
4. Pisgah Laboratories, Inc. Scores a Triple Play in the World Series Against Prescription Drug Abuse
5. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
6. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
7. SuccessEHS "Forward Together" Customer Conference Begins
8. Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial
9. Insmed Incorporated Begins Screening Patients For TARGET-NTM U.S. Clinical Trial Of ARIKACE® In Patients With Non-tuberculous Mycobacterial Lung Disease
10. Siteman Cancer Center at Barnes-Jewish and Washington University Begins Imaging with First ViewRay System
11. Countdown Begins For AdvaMed 2012: The Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... JUNCTION, N.J. , May 26, 2015 ... critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine adsorber ... Dr. Phillip Chan , Chief Executive Officer, will ... on Monday, June 1, 2015 at 10:30AM PDT / ... Los Angeles , California.  Dr. Chan will also ...
(Date:5/26/2015)... 26, 2015  Shapiro+Raj, a leading independent insights and ... to Managing Director. In her new role, she will ... CarbonSix, Shapiro+Raj,s pharmaceutical practice as well as the company,s ... been on a strong growth trajectory in double digits ... assignments from existing clients and strategic new business wins. ...
(Date:5/26/2015)... -- Connected health infrastructure is emerging as a ... diagnosis, monitoring and prevention in the healthcare industry. ... must first ensure that interoperability and connectivity standards ... http://photos.prnewswire.com/prnh/20150526/218313LOGO New analysis from ... and Interoperability, finds that the adoption of connected ...
Breaking Medicine Technology:CytoSorbents to Present at the LD Micro Invitational on June 1st 2CytoSorbents to Present at the LD Micro Invitational on June 1st 3Shapiro+Raj Promotes Kim Mizrahi to Managing Director for New York 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 3
... Pharmaceuticals Inc. (Nasdaq: CPIX ) announced ... lots of Acetadote® (acetylcysteine) Injection, the Company,s injectable treatment ... a potentially toxic quantity of acetaminophen. Cumberland informed the ... to voluntarily recall these lots of Acetadote as a ...
... 2010 Stereotaxis, Inc. (Nasdaq: STXS ) ... the Remote Magnetic Navigation System in the electrophysiology (EP) ... train clinicians planning to install Stereotaxis at their own ... Navigation System growing steadily, there is significant new demand ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials 2Cumberland Pharmaceuticals Announces Voluntary Recall of Acetadote® Vials 3Stereotaxis Announces Global Initial Training Site at University of Chicago 2Stereotaxis Announces Global Initial Training Site at University of Chicago 3
(Date:5/26/2015)... Scientists at the University of Pennsylvania believe they ... patients benefit from immunotherapy; surgery may be the key. ... new research. Click here to read it now. ... and pulmonology theorized that, because large mesothelioma tumors have ... drugs might work better if the tumor size could ...
(Date:5/26/2015)... The best and most convenient method of tracking ... pocket. That’s because Life Fitness, the global leader in ... sync with the most popular built-in fitness mobile apps ... automatically transmitting data collected directly from Life Fitness cardio ... the millions of iPhone and Android users and exercisers ...
(Date:5/26/2015)... 26, 2015 General Networks Corporation ... Corporation. The alliance ensures joint customers will benefit ... General Networks’ expertise in building enterprise content and ... will help customers integrate, manage and operationalize their ... processes. , “Our customers are seeking tools to ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 ... ceremonies during the Memorial Day weekend, celebrating the ... occurred on Pacifica’s picturesque Ladera Lane campus, located ... faculty, and alumni traveled to Santa Barbara from ... events. , The 2015 commencement ceremonies ...
(Date:5/26/2015)... May 26, 2015 Dearborn Ear, Nose ... the launch of their new and improved website to ... and potential patients. Dearborn Ear, Nose & Throat’s new ... visitors to view the website seamlessly on any desktop ... to the Dearborn Ear, Nose & Throat ...
Breaking Medicine News(10 mins):Health News:Researchers Say Surgery May Restore Effectiveness of Immunotherapy for Mesothelioma, According to Surviving Mesothelioma 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 2Health News:Life Fitness Expands Its Compatibility with Popular Fitness Apps 3Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:Dearborn Ear, Nose & Throat Launches ‘Responsive Design’ Website 2
... ordering chest CT examinations translates into positive examinations three-quarters ... study, conducted at Massachusetts General Hospital in Boston, of ... a decision support system, found that 76% of patients ... "Rising concerns about radiation risks, imaging growth and reimbursement ...
... A new analysis suggests the benefits of mammography screening ... 40 to 49 who are at an increased risk of ... out of every five American women. The researchers also ... to film mammography. These findings, with contributions from three national ...
... State University researchers have invented a protein purifier that ... The details of the invention, which appear in a ... that MSU chemists Merlin Bruening and Greg Baker,s high-performance ... step in the development of some new drugs. ...
... Dotinga HealthDay Reporter , MONDAY, April 30 (HealthDay ... a commonly used insecticide to unusual changes in the brain ... that the pesticide is at fault. The findings ... as chlorpyrifos, which is used to treat farm products in ...
... officer calling for backup while also keeping a strong hold ... a two-tier approach to fighting off a threat, new research ... the first time, the scientists managed to capture that reaction ... model of virus-infected brain cells, while also sending signals to ...
... Control and Prevention (CDC) found that one-third of U.S. adults ... depression. According to findings that appear today in Arthritis ... behalf of the American College of Rheumatology (ACR), anxiety is ... despite more clinical focus on the latter mental health condition. ...
Cached Medicine News:Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 2Health News:Research examines when benefits of screening mammography outweigh the harms for women in their 40s 3Health News:MSU invention could help pharmaceutical industry save money 2Health News:Insecticide Linked to Brain Abnormalities in Kids 2Health News:Insecticide Linked to Brain Abnormalities in Kids 3Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 2Health News:How does the immune system fight off threats to the brain? New research yields fresh insight 3Health News:One-third of adult Americans with arthritis battle anxiety or depression 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: